Bone tissue compositional differences in women with and without osteoporotic fracture.
It is generally accepted that the hallmark of osteoporosis is a reduction in bone mass. There is significant overlap, however, in bone mineral density between osteoporotic and normal individuals. This study examined the chemical composition of bone tissue obtained from women who had sustained a fracture and women without fracture to determine if there are differences between the two groups. Nineteen fractured and eleven non-fractured proximal femurs were obtained, matched for age and bone volume fraction obtained from micro-computed tomography. Trabecular bone specimens were examined by Raman spectroscopy to determine measures of chemical composition. A subset of the specimens was utilized to compare locations at the fracture and regions at least 2 mm away from apparent tissue damage using Raman spectroscopy. In addition, fifteen iliac crest biopsies each were obtained from women who had sustained a fracture and from normal controls. Raman spectroscopy was used to determine measures of chemical composition of trabecular and cortical bone. The results demonstrated that femoral bone tissue in the region of visible damage had a trend towards differences compared to regions at least 2 mm from visible damage. Femoral trabecular bone in fractured women had a higher carbonate/amide I area ratio than in unfractured women. Iliac crest biopsies revealed a higher carbonate/phosphate ratio in cortical bone from women who had sustained a fracture. Results suggest that the chemical composition of bone tissue may be an additional risk factor for osteoporotic fracture.
McCreadie
Barbara R
BR
Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, 2015 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA. riemer@umich.edu
Morris
Michael D
MD
Chen
Tso-Ching
TC
Sudhaker Rao
D
D
Finney
William F
WF
Widjaja
Effendi
E
Goldstein
Steven A
SA
D000368:Aged; D015519:Bone Density; D001842:Bone and Bones / Q000737:chemistry*; D016022:Case-Control Studies; D005260:Female; D005270:Femur Head / Q000737:chemistry; D050723:Fractures, Bone / Q000209:etiology* / Q000378:metabolism*; D006801:Humans; D007085:Ilium / Q000737:chemistry; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications* / Q000378:metabolism*; D012307:Risk Factors; D013059:Spectrum Analysis, Raman